# US 2012/0253012 A1 · Method for preparing lipopeptide compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253012 A1
- Document ID: US20120253012A1
- Status: Published application
- Kind: A1
- Application number: 13/394,243
- Filed: 2010-09-07
- Published: 2012-10-04
- Earliest claimed: 2009-09-07
- Assignees: Nissan Chemical Industries, Ltd.
- Inventors: Nobuyuki Kakiuchi; Takeaki Shoji; Kazuki Hirasada; Keigo Matsumoto; Hiroki Yamaguchi
- Web page: https://patentgrep.com/patent/US20120253012A1

## CPC

- A61K 38/05: Dipeptides
- A61K 47/543: {Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}
- C07K 1/026: {by fragment condensation in solution}
- C07K 1/107: by chemical modification of precursor peptides
- C07K 1/1072: {by covalent attachment of residues or functional groups}
- C07K 1/1075: {by covalent attachment of amino acids or peptide residues}
- C07K 5/06: Dipeptides
- C07K 5/06026: {the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala}
- C07K 5/06043: {Leu-amino acid}
- C07K 5/06052: {Val-amino acid}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

There is provided a practical method for preparing lipopeptide compounds, which method is capable of inexpensive mass production without requiring complicated operations. The lipopeptide compound of formula (3): is produced by reacting an ester compound of formula (1): with an α-amino acid compound of formula (2): in the presence of a base and within a solvent containing a nonpolar organic solvent.

## Claims

### Claim 1

A method of preparing a lipopeptide compound of formula (3):
(where R1 is a C9-23 aliphatic group; R2 is a hydrogen atom or a C1-4 alkyl group which may have a C1-2 branch; and R4 is a —(CH2)n—X group in which n is a number from 1 to 4 and X is an amino group, a guanidino group, a —CONH2 group, a 5-membered or 6-membered ring which may contain from 1 to 3 nitrogen atoms, or a fused heterocycle composed of a 5-membered ring and a 6-membered ring) or a pharmaceutically usable salt thereof,
the method comprising: reacting an ester compound of formula (1):
(where R1 and R2 are as defined above, and R3 is a C1-6 alkyl group, a C1-6 haloalkyl group, a C1-6 hydroxyalkyl group, or an aryl group which may be substituted with a C1-6 alkyl group) with an α-amino acid compound of formula (2):
(where R4 is as defined above) in the presence of a base and within a solvent containing a nonpolar organic solvent.

### Claim 2 (depends on 1)

The preparation method according to claim 1, wherein the solvent contains a nonpolar organic solvent and an alcohol.

### Claim 3 (depends on 1)

The preparation method according to claim 1, wherein either n is a number from 1 to 4 and X is an amino group, a guanidino group or a —CONH2 group, or n is 1 and X is a pyrrole group, an imidazole group, a pyrazole group or an imidazole group.

### Claim 4 (depends on 1)

The preparation method according to claim 1, wherein R1 is a C11-21 linear aliphatic group which may have from 0 to 2 unsaturated bonds.

### Claim 5 (depends on 1)

The preparation method according to claim 1, wherein R2 is a hydrogen atom or a C1-3 alkyl group which may have a C1 branch.

### Claim 6 (depends on 1)

The preparation method according to claim 1, wherein R2 is a hydrogen atom, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl group; and R4 is an aminomethyl, aminoethyl, 3-aminopropyl, 4-aminobutyl, carbamoylmethyl, 2-carbamoylethyl, 3-carbamoylbutyl, 2-guanidinoethyl, 3-guanidinopropyl, pyrrolemethyl, imidazolemethyl, pyrazolemethyl or 3-indolemethyl group.

### Claim 7 (depends on 6)

The preparation method according to claim 6, wherein R2 is a hydrogen atom, methyl, isopropyl, isobutyl or sec-butyl group; and R4 is a 4-aminobutyl, carbamoylmethyl, 2-carbamoylethyl, 3-guanidinopropyl, imidazolemethyl or 3-indolemethyl group.

### Claim 8 (depends on 1)

The preparation method according to claim 1, wherein R3 is a methyl or ethyl group.

### Claim 9 (depends on 1)

The preparation method according to claim 1, wherein the base is at least one selected from among alkali metals, inorganic acid salts of alkali metals, alkali metal hydroxides, alkali metal alkoxides, alicyclic amines, and alcohol solutions or alcohol dispersions thereof.

### Claim 10 (depends on 9)

The preparation method according to claim 9, wherein the base is at least one selected from among a metallic sodium, metallic potassium, sodium carbonate, potassium carbonate, potassium phosphate, sodium phosphate, sodium hydroxide, potassium hydroxide, sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, potassium t-butoxide, 1,8-diazabicyclo[5.4.0]-7-undecene, 1,5-diazabicyclo[4.3.0]-5-nonene, and alcohol solutions or alcohol dispersions thereof.

### Claim 11 (depends on 10)

The preparation method according to claim 10, wherein the base is selected from among sodium methoxide and methanol solutions or methanol dispersions thereof.

### Claim 12 (depends on 1)

The preparation method according to claim 1, wherein the nonpolar organic solvent is at least one selected from the group consisting of aromatic compounds, saturated aliphatic compounds and unsaturated aliphatic compounds.

### Claim 13 (depends on 12)

The preparation method according to claim 12, wherein the nonpolar organic solvent is at least one selected from the group consisting of toluene, xylene, ortho-dichlorobenzene, pentane, hexane, heptane, octane, cyclopentane, cyclohexane, methylcyclohexane, cycloheptane and 1-hexene.

### Claim 14 (depends on 2)

The preparation method according to claim 2, wherein the solvent includes cyclohexane and methanol or ethanol.

### Claim 15 (depends on 1)

The preparation method according to claim 1, wherein the reaction of the ester compound of formula (1) with the α-amino acid compound of formula (2) is carried out at a reaction temperature of 60±5° C.

### Claim 16 (depends on 1)

The preparation method according to claim 1, which includes a step of neutralizing with a hydrogen halide a product obtained from the reaction of the ester compound of formula (1) with the α-amino acid compound of formula (2).

### Claim 17 (depends on 16)

The preparation method according to claim 16, wherein the neutralization step is carried out in a solvent containing water and an alcohol.

### Claim 18

A method of preparing a lipopeptide compound of formula (3):
(where R1 is a C9-23 aliphatic group; R2 is a hydrogen atom or a C1-4 alkyl group which may have a C1-2 branch; and R4 is a hydrogen atom, a C1-7 alkyl group which may have a C1-3 branch, a phenylmethyl group, a phenyethyl group, a —(CH2)n—X group in which n is a number from 1 to 4 and X is an amino group, a guanidino group, a —CONH2 group, a 5-membered or 6-membered ring which may contain from 1 to 3 nitrogen atoms, or a fused heterocycle composed of a 5-membered ring and a 6-membered ring) or a pharmaceutically usable salt thereof,
the method comprising:
a step of reacting a compound of formula (4):
(where X is a halogen atom, a C1-6 alkoxy group, or a —OC(O)R1 group in which R1 is as defined above) with a compound of formula (5):
(where R2 is as defined above, and R3 is a C1-6 alkyl group, a C1-6 haloalkyl group, a C1-6 hydroxyalkyl group, or an aryl group which may be substituted with a C1-6 alkyl group) to obtain an ester compound of formula (1):
(where R1, R2 and R3 are as defined above); and
a step of reacting the ester compound of formula (1) with an α-amino acid compound of formula (2):
(where R4 is as defined above) in the presence of a base and within a solvent containing a nonpolar organic solvent.
